U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07560046) titled 'Combating Related Epidemics in HCV' on April 02.
Brief Summary: This is a two-arm cluster randomized control trial to evaluate the effectiveness of a single-visit point-of-care (POC) test and treat bundle (intervention arm) compared to the current standard-of-care (SOC, control arm). 1:1 randomization occurs at the site level.
Study Start Date: Aug. 01, 2026
Study Type: INTERVENTIONAL
Condition:
HIV - Human Immunodeficiency Virus
Hepatitis B Virus (HBV)
HEPATITIS C (HCV)
Intervention:
DEVICE: Cepheid GeneXpert HCV Test
Cepheid Xpert HCV Test, performed on the GeneXpert Xpress system, in an automated in vitro reverse transcripti...